Correlation Between Puma Biotechnology and PTC Therapeutics

Can any of the company-specific risk be diversified away by investing in both Puma Biotechnology and PTC Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Puma Biotechnology and PTC Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Puma Biotechnology and PTC Therapeutics, you can compare the effects of market volatilities on Puma Biotechnology and PTC Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Puma Biotechnology with a short position of PTC Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Puma Biotechnology and PTC Therapeutics.

Diversification Opportunities for Puma Biotechnology and PTC Therapeutics

0.34

Correlation Coefficient

Puma Biotechnology  PTC Therapeutics

Weak diversification

The 3 months correlation between Puma and PTC is 0.34. Overlapping area represents the amount of risk that can be diversified away by holding Puma Biotechnology and PTC Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on PTC Therapeutics and Puma Biotechnology is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Puma Biotechnology are associated (or correlated) with PTC Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of PTC Therapeutics has no effect on the direction of Puma Biotechnology i.e., Puma Biotechnology and PTC Therapeutics go up and down completely randomly.

Pair Corralation between Puma Biotechnology and PTC Therapeutics

Given the investment horizon of 90 days Puma Biotechnology is expected to generate 2.31 times less return on investment than PTC Therapeutics. In addition to that, Puma Biotechnology is 1.9 times more volatile than PTC Therapeutics. It trades about 0.03 of its total potential returns per unit of risk. PTC Therapeutics is currently generating about 0.15 per unit of volatility. If you would invest  4,584  in PTC Therapeutics on December 25, 2024 and sell it today you would earn a total of  1,043  from holding PTC Therapeutics or generate 22.75% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

Puma Biotechnology  vs.  PTC Therapeutics

Puma Biotechnology

Risk-Adjusted Performance

Insignificant

Compared to the overall equity markets, risk-adjusted returns on investments in Puma Biotechnology are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly unsteady basic indicators, Puma Biotechnology may actually be approaching a critical reversion point that can send shares even higher in April 2025.

PTC Therapeutics

Risk-Adjusted Performance

Good

Compared to the overall equity markets, risk-adjusted returns on investments in PTC Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively uncertain fundamental indicators, PTC Therapeutics unveiled solid returns over the last few months and may actually be approaching a breakup point.

Pair Trading with Puma Biotechnology and PTC Therapeutics

The main advantage of trading using opposite Puma Biotechnology and PTC Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Puma Biotechnology position performs unexpectedly, PTC Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in PTC Therapeutics will offset losses from the drop in PTC Therapeutics' long position.

The idea behind Puma Biotechnology and PTC Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.